These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Systematic Proteome Profiling of Maternal Plasma for Development of Preeclampsia Biomarkers. Lim JH; Lim JM; Lee HM; Lee HJ; Kwak DW; Han YJ; Kim MY; Jung SH; Kim YR; Ryu HM; Kim KP Mol Cell Proteomics; 2024 Sep; 23(9):100826. PubMed ID: 39111712 [TBL] [Abstract][Full Text] [Related]
3. Systematic proteomics analysis of lysine acetylation reveals critical features of placental proteins in pregnant women with preeclampsia. Shangguan Y; Wang Y; Shi W; Guo R; Zeng Z; Hu W; Cai W; Yan Q; Xu Y; Tang D; Dai Y J Cell Mol Med; 2021 Nov; 25(22):10614-10626. PubMed ID: 34697885 [TBL] [Abstract][Full Text] [Related]
4. Screening of serum biomarkers of preeclampsia by proteomics combination with bioinformatics. Ling Y; Su J; Lin J; Wang S Hypertens Pregnancy; 2019 Aug; 38(3):184-192. PubMed ID: 31284791 [No Abstract] [Full Text] [Related]
5. Complement component C4A and apolipoprotein A-I in plasmas as biomarkers of the severe, early-onset preeclampsia. Zhang H; Zhang Y; Yang F; Li L; Liu S; Xu Z; Wang J; Sun S Mol Biosyst; 2011 Aug; 7(8):2470-9. PubMed ID: 21677994 [TBL] [Abstract][Full Text] [Related]
6. A proteomic approach identifies early pregnancy biomarkers for preeclampsia: novel linkages between a predisposition to preeclampsia and cardiovascular disease. Blumenstein M; McMaster MT; Black MA; Wu S; Prakash R; Cooney J; McCowan LM; Cooper GJ; North RA Proteomics; 2009 Jun; 9(11):2929-45. PubMed ID: 19444803 [TBL] [Abstract][Full Text] [Related]
7. Serum protein profile analysis via label-free quantitation proteomics in patients with early-onset preeclampsia. Ji Q; Zhang S; Jiang W; Wang J; Luan Y; Xin Q J Obstet Gynaecol; 2023 Dec; 43(2):2259982. PubMed ID: 37743728 [TBL] [Abstract][Full Text] [Related]
8. Different profiles of circulating arginase 2 in subtypes of preeclampsia pregnant women. Bertozzi-Matheus M; Bueno-Pereira TO; Viana-Mattioli S; Carlström M; Cavalli RC; Sandrim VC Clin Biochem; 2021 Jun; 92():25-33. PubMed ID: 33713637 [TBL] [Abstract][Full Text] [Related]
9. Gene-gene interactions in the NAMPT pathway, plasma visfatin/NAMPT levels, and antihypertensive therapy responsiveness in hypertensive disorders of pregnancy. Luizon MR; Palei ACT; Belo VA; Amaral LM; Lacchini R; Duarte G; Cavalli RC; Sandrim VC; Tanus-Santos JE Pharmacogenomics J; 2017 Oct; 17(5):427-434. PubMed ID: 27168100 [TBL] [Abstract][Full Text] [Related]
10. Proteomic profiling reveals α1-antitrypsin, α1-microglobulin, and clusterin as preeclampsia-related serum proteins in pregnant women. Hsu TY; Hsieh TT; Yang KD; Tsai CC; Ou CY; Cheng BH; Wong YH; Hung HN; Chou AK; Hsiao CC; Lin H Taiwan J Obstet Gynecol; 2015 Oct; 54(5):499-504. PubMed ID: 26522099 [TBL] [Abstract][Full Text] [Related]
11. Alterations to the maternal circulating proteome after preeclampsia. Murphy MS; Bytautiene E; Saade G; Smith GN Am J Obstet Gynecol; 2015 Dec; 213(6):853.e1-9. PubMed ID: 26476107 [TBL] [Abstract][Full Text] [Related]
12. Isobaric tag for relative and absolute quantitation based quantitative proteomics reveals unique urinary protein profiles in patients with preeclampsia. Ding W; Qiu B; Cram DS; Chen X; Li S; Zhou X; Liu J; Wu Z; Song Y J Cell Mol Med; 2019 Aug; 23(8):5822-5826. PubMed ID: 31232531 [TBL] [Abstract][Full Text] [Related]
13. Comprehensive maternal serum proteomic profiles of preclinical and clinical preeclampsia. Rasanen J; Girsen A; Lu X; Lapidus JA; Standley M; Reddy A; Dasari S; Thomas A; Jacob T; Pouta A; Surcel HM; Tolosa JE; Gravett MG; Nagalla SR J Proteome Res; 2010 Aug; 9(8):4274-81. PubMed ID: 20568817 [TBL] [Abstract][Full Text] [Related]
14. CircRNA-0004904, CircRNA-0001855, and PAPP-A: Potential Novel Biomarkers for the Prediction of Preeclampsia. Jiang M; Lash GE; Zhao X; Long Y; Guo C; Yang H Cell Physiol Biochem; 2018; 46(6):2576-2586. PubMed ID: 29758559 [TBL] [Abstract][Full Text] [Related]
15. Proteomic signatures predict preeclampsia in individual cohorts but not across cohorts - implications for clinical biomarker studies. Ghaemi MS; Tarca AL; Romero R; Stanley N; Fallahzadeh R; Tanada A; Culos A; Ando K; Han X; Blumenfeld YJ; Druzin ML; El-Sayed YY; Gibbs RS; Winn VD; Contrepois K; Ling XB; Wong RJ; Shaw GM; Stevenson DK; Gaudilliere B; Aghaeepour N; Angst MS J Matern Fetal Neonatal Med; 2022 Dec; 35(25):5621-5628. PubMed ID: 33653202 [TBL] [Abstract][Full Text] [Related]
16. Screening of differentially expressed proteins from syncytiotrophoblast for severe early-onset preeclampsia in women with gestational diabetes mellitus using tandem mass tag quantitative proteomics. Sun X; Qu T; He X; Yang X; Guo N; Mao Y; Xu X; Sun X; Zhang X; Wang W BMC Pregnancy Childbirth; 2018 Nov; 18(1):437. PubMed ID: 30404616 [TBL] [Abstract][Full Text] [Related]
17. Screening of differentially expressed proteins in placentas from patients with late-onset preeclampsia. He A; Wang J; Yang X; Liu J; Yang X; Wang G; Li R Proteomics Clin Appl; 2022 Mar; 16(2):e2100053. PubMed ID: 34704665 [TBL] [Abstract][Full Text] [Related]
18. eNOS haplotypes affect the responsiveness to antihypertensive therapy in preeclampsia but not in gestational hypertension. Sandrim VC; Palei AC; Luizon MR; Izidoro-Toledo TC; Cavalli RC; Tanus-Santos JE Pharmacogenomics J; 2010 Feb; 10(1):40-5. PubMed ID: 19704415 [TBL] [Abstract][Full Text] [Related]
19. Alpha-1-antitrypsin acts as a preeclampsia-related protein: a proteomic study. Feng YL; Zhou CJ; Li XM; Liang XQ Gynecol Obstet Invest; 2012; 73(3):252-9. PubMed ID: 22414876 [TBL] [Abstract][Full Text] [Related]
20. Placental Proteomics Provides Insights into Pathophysiology of Pre-Eclampsia and Predicts Possible Markers in Plasma. Mary S; Kulkarni MJ; Malakar D; Joshi SR; Mehendale SS; Giri AP J Proteome Res; 2017 Feb; 16(2):1050-1060. PubMed ID: 28030762 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]